Reversal of neuromuscular blockade.
Bevan
D R
DR
Department of Anesthesia, Vancouver General Hospital, B.C., Canada.
Donati
F
F
Kopman
A F
AF
D000367:Age Factors; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000494:pharmacology*; D004347:Drug Interactions; D004491:Edrophonium / Q000009:adverse effects / Q000494:pharmacology; D006801:Humans; D009388:Neostigmine / Q000009:adverse effects / Q000494:pharmacology; D009466:Neuromuscular Blocking Agents / Q000037:antagonists & inhibitors*; D011729:Pyridostigmine Bromide / Q000009:adverse effects / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D009466:Neuromuscular Blocking Agents; D009388:Neostigmine; D004491:Edrophonium; D011729:Pyridostigmine Bromide